Disease Areas
News and analysis on disease research and diagnostics.
UK Government Inks $172.9M Contract With Thriva to Enable COVID-19 Antibody Testing at Home
A two-year contract with blood-based testing firm Thriva will enable capillary blood testing to detect antibodies against SARS-CoV-2 in the UK, according to the government.
360Dx Index Continues Growth in July, Increasing 5 Percent
Of the 29 companies in the index, 16 saw increases in their stock prices, while 13 saw declines.
InterVenn Biosciences Closes $201M Series C Round
The company said it planned to use the funds for the development of a liquid biopsy assay for predicting patient response to immune checkpoint inhibitors.
Veracyte Aims to Broaden Reach of Decipher Prostate Assay as Studies Continue to Expand Utility
Premium
The company reported significant momentum in test volumes for the second quarter of this year as new publications shore up utility evidence and open new applications.
DiaSorin Q2 Revenues Rise 20 Percent on SARS-CoV-2 Testing Demand
DiaSorin posted Q2 molecular revenues of €69.4 million, up 23 percent year over year from €56.6 million.